PapersPMID:32503652
The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- RCT · 8 weeks
- Dose studied, every finding
- 1 g capsules, three capsules three times per day after each meal, 8 weeks (Methods)
- Population, every finding
- Adults aged 30-60 with type 2 diabetes, BMI 25-35 and gastrointestinal symptoms; 42 completers, 21 per arm; dill powder against starch placebo for 8 weeks
What moved
How to read these marks →- Decreases LDL cholesterol
moderate
“Furthermore, the serum levels of LDL-C decreased to a greater extent in the intervention group between the start and the end of the study than in the control group (−9.76 ± 19.08 vs 3.09 ± 14.07 mg/dl, respectively; P = 0.017).”
- Interests
- Industry funded
- Increases HDL cholesterol
moderate
“Furthermore, the mean changes in serum levels of HDL were significantly higher in the intervention group compared to the control group (2.59 ± 4.51 vs −1.38 ± 4.60 mg/dl, respectively; P = 0.004).”
- Interests
- Industry funded
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Patients with type 2 diabetes mellitus and gastrointestinal symptoms, Golestan Hospital, Ahvaz, Iran; dried dill (Anethum graveolens) leaves milled to powder in capsules. The Methods text says 100 patients, 48 randomised and 42 completed; the Methods describe three capsules of 1 g three times per day, while the abstract (not quoted) says 3 g/day
- Participants
- 42
- Comparator
- placebo
- Duration
- 56 days
- Endpoints measured
- 80